Method of treating inflammatory and immune diseases using inhibitors of IkappaB kinase (IKK)

Details for Australian Patent Application No. 2002247059 (hide)

Owner Bristol-Myers Squibb Company

Inventors Burke, James, R.; ZUSI, Fred, Christopher; Qiu, Yuping; Townsend, Robert, M.; Nadler, Steven

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002247059

PCT Pub. Number WO2002/060386

Priority 09/965,977 27.09.01 US; 60/265,853 01.02.01 US

Filing date 1 February 2002

Wipo publication date 12 August 2002

Acceptance publication date 16 November 2006

International Classifications

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002247059

16 November 2006 Application Accepted

  Published as AU-B-2002247059

15 March 2007 Standard Patent Sealed

27 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002247060-NOVEL INOSITOL POLYPHOSPHATE KINASE GENES AND USES THEREOF

2002247058-TEST STRUCTURES FOR ELECTRICAL LINEWIDTH MEASUREMENT AND PROCESSES FOR THEIR FORMATION